Nexcella
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11400 W Olympic Blvd Ste 200, Los Angele...Website
www.nexcella.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Nexcella
Nexcella, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative CAR-T cell therapies for patients suffering from AL Amyloidosis and select immune-mediated diseases. Their primary product, NXC-201, is currently being evaluated in the NEXICART-2 clinical trial for its safety and efficacy in treating relapsed and refractory AL Amyloidosis. The company aims to provide transformative, one-time treatments that are more accessible to patients and medical centers across the U.S. Nexcella operates as a subsidiary of Immix Biopharma, which supports its mission to improve patient outcomes.Explore more
Nexcella Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nexcella your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Nexcella recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Nexcella
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Nexcella had a recent Job posting/layoffs
Check if Nexcella has recently received funding, and reach out quickly before it becomes old news!
Nexcella, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Nexcella has new funding data
Product Launch: Get notified when Nexcella launches new products
Website visits: Recent activity has been detected on your website
Check out if Nexcella is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Nexcella
Compare insights from companies similar to Nexcella, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nexcella is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nexcella is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nexcella.
Nexcella Tech Stack
A closer look at the technologies used by Nexcella
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nexcella
Sign Up For FreeTo access detailed company insights
Nexcella, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative CAR-T cell therapies for patients suffering from AL Amyloidosis and select immune-mediated diseases. Their primary product, NXC-201, is currently being evaluated in the NEXICART-2 clinical trial for its safety and efficacy in treating relapsed and refracto... Read More
